Health insurance; prohibit modifications on renewal of covered and prescribed prescription drug's contracted benefit level.
Impact
The bill's implementation is expected to provide insured individuals with greater stability concerning their prescription drug coverage. By ensuring that health insurance providers cannot unilaterally change the conditions of drug coverage at renewal, advocates argue that it will lead to better treatment adherence and health outcomes, particularly for those with chronic health conditions who rely on consistent medication management. Furthermore, it aims to limit unexpected financial burdens on patients who may face increased costs or obstacles to accessing their necessary medications.
Summary
House Bill 698 aims to protect insured individuals in Mississippi by prohibiting health insurance plans from altering the contracted benefit level for any prescription drug that has been approved or covered in the previous plan year. Specifically, if a physician prescribes a drug for a medical condition or mental illness, the health insurance plan is not allowed to modify the conditions under which that drug is covered upon renewal. This bill is set to take effect on July 1, 2026, and applies to all forms of health insurance policies issued in the state.
Contention
Despite its intended benefits, the bill has raised concerns about potential impacts on insurance companies and the flexibility of health plans to manage their formularies. Opponents worry that limiting the ability to modify covered prescription drugs may lead to increased overall costs for insurance providers, which could compromise the financial sustainability of health insurance covered operations. Additionally, the bill specifies certain scenarios where changes to drug coverage could still occur, such as safety concerns from the FDA or the drug being removed from the market, which presents a balance between patient protection and the necessary adaptability of health plans.